Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Align Research update note

12 Oct 2017 07:00

RNS Number : 3758T
Obtala Limited
11 October 2017
 

Obtala Limited - Conviction Buy. Target price 38.18p

Step change in revenues evident following interims & Q3 update

Obtala Limited is an Africa focussed forestry and agriculture company with a goal of becoming one of Sub-Saharan Africa's largest sustainable food and timber producers.

Interims show period of investment & Woodbois value made apparent

Obtala posted an operating loss of $3.8 million for the six months to 30th June 2017 but a statutory profit of $22.7 million following a gain on the acquisition of Woodbois. An independent valuation of the forestry and timber trading firm added $53.3 million to Obtala's biological asset value. This compares to a revised purchase price for Woodbois of $12.2 million.

Q3 update shows further progress and additional funds raised

The three months to September 2017 saw the end of the forestry close cutting season in Mozambique, the first significant harvests from the agriculture division and the first contribution from the Woodbois acquisition. An additional $2 million has also been raised to support growth via a further preference share in the forestry subsidiary Argento Limited.

Corporate structure re-organised with new Boards appointed

Obtala will now report to the markets via the three divisions of Timber Trading, Timber Production (together the Forestry division) and Agriculture Production. To support this, new boards have been appointed to the Argento (forestry) and Montara (agriculture) subsidiaries.

DCF derived target price of 38.18p suggests 117% upside

Obtala is now seeing a step change in revenue and profit growth across the three divisions of the business. Nevertheless, the shares trade at a substantial discount to net assets, with the market cap c.90% covered by Obtala's stake in Argento alone. Our DCF analysis suggests a target price of 38.18p, therefore we retain our stance of Conviction Buy.

To download the full note visit http://www.alignresearch.co.uk/cpt-company/obtala/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMBBPTMBBBBBR
Date   Source Headline
1st Apr 20191:12 pmRNSHolding(s) in Company
27th Mar 20197:00 amRNSEquity Raise and Group Restructuring Update
20th Mar 20191:20 pmRNSResults of General Meeting and Change of Name
14th Mar 20195:32 pmRNSHolding(s) in Company
13th Mar 20191:25 pmRNSHolding(s) in Company
11th Mar 20197:00 amRNSHolding(s) in Company
7th Mar 20197:00 amRNSEquity Raise
28th Feb 20197:00 amRNSNotice of General Meeting
21st Jan 20197:01 amRNSDirector/PDMR Shareholding
21st Jan 20197:00 amRNSLong Term Incentive Plan
16th Jan 20191:44 pmRNSHolding(s) in Company
14th Jan 20198:08 amRNSQuarterly Update - Replacement
14th Jan 20197:00 amRNSQuarterly Update
11th Jan 20197:00 amRNSAppointment of New Nominated Adviser and Broker
10th Jan 20197:00 amRNSGroup Reorganisation and Fundraising
21st Nov 201812:49 pmRNSUpdate re: Nominated Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
2nd Nov 20183:19 pmRNSDirector/PDMR Shareholding
2nd Nov 20183:14 pmRNSTotal Voting Rights
2nd Nov 20187:00 amRNSDirector/PDMR Shareholding
1st Nov 201811:43 amRNSNominated Adviser Status
1st Nov 20187:00 amRNSDirector/PDMR Shareholding
31st Oct 20187:00 amRNSDirector/PDMR Shareholding
30th Oct 20184:02 pmRNSDirector/PDMR Shareholding
30th Oct 201810:01 amRNSFunding Closed
30th Oct 20188:01 amRNSCapital raise, board, name change,strategic update
22nd Oct 201810:19 amRNSHolding(s) in Company
2nd Oct 20187:00 amRNSQuarterly update
14th Sep 20181:12 pmRNSDirector/PDMR Shareholding
14th Sep 20189:30 amRNSDirector/PDMR Shareholding
13th Sep 201810:37 amRNSDirector/PDMR Shareholding
13th Sep 20189:32 amRNSDirector/PDMR Shareholding
12th Sep 20189:13 amRNSDirector/PDMR Shareholding
11th Sep 20182:57 pmRNSDirector/PDMR Shareholding
11th Sep 201811:01 amRNSDirector/PDMR Shareholding
10th Sep 20181:52 pmRNSDirector/PDMR Shareholding
5th Sep 201811:02 amRNSDirector/PDMR Shareholding
4th Sep 20183:41 pmRNSDirector/PDMR Shareholding
3rd Sep 20184:43 pmRNSHalf-year Report
29th Aug 20189:21 amRNSHolding(s) in Company
26th Jul 20184:10 pmRNSDirector/PDMR Shareholding
23rd Jul 201811:32 amRNSDirector/PDMR Shareholding
23rd Jul 201810:27 amRNSDirector/PDMR Shareholding
23rd Jul 201810:08 amRNSHolding(s) in Company
18th Jul 20185:05 pmRNSHolding(s) in Company
16th Jul 20189:19 amRNSDirector/PDMR Shareholding Amendment
13th Jul 20182:36 pmRNSHolding(s) in Company
13th Jul 20182:09 pmRNSDirector/PDMR Shareholding
11th Jul 201810:12 amRNSDirector/PDMR Shareholding
9th Jul 20182:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.